|
SELT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.482400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.962800E-01 |
| Normal-vs-Stage2 |
7.671200E-01 |
| Normal-vs-Stage3 |
5.028200E-01 |
| Normal-vs-Stage4 |
2.862400E-01 |
| Stage1-vs-Stage2 |
2.512200E-01 |
| Stage1-vs-Stage3 |
5.454000E-02 |
| Stage1-vs-Stage4 |
4.856000E-02 |
| Stage2-vs-Stage3 |
8.097400E-01 |
| Stage2-vs-Stage4 |
5.417600E-01 |
| Stage3-vs-Stage4 |
6.505400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.031200E-01 |
| Normal-vs-AfricanAmerican |
3.170800E-01 |
| Normal-vs-Asian |
5.923400E-01 |
| Caucasian-vs-AfricanAmerican |
2.027800E-01 |
| Caucasian-vs-Asian |
5.043800E-01 |
| AfricanAmerican-vs-Asian |
4.894600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.818400E-01 |
| Normal-vs-Female |
5.415600E-01 |
| Male-vs-Female |
2.064000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.009000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.370200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.829800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.817200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.192000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.070400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.829400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.398200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.790200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.381400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.821610E-01 |
| Classical-VS-Follicular |
3.653700E-02 |
| Classical-VS-Other |
3.928400E-01 |
| Classical-VS-Normal |
2.365400E-01 |
| Tall-VS-Follicular |
9.590200E-01 |
| Tall-VS-Other |
8.539600E-01 |
| Tall-VS-Normal |
6.030800E-01 |
| Follicular-VS-Other |
9.000400E-01 |
| Follicular-VS-Normal |
5.088800E-01 |
| Other-VS-Normal |
6.162800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.012000E-01 |
| Normal-vs-N1 |
2.713000E-01 |
| N0-vs-N1 |
4.098800E-01 |
|
|
